Celebrating 25 Years: CritiCare Asia & IIFA Foundation Offer Free Check-Ups to 500 Workers

Mumbai (Maharashtra) [India], September 14L: CritiCare Asia Multi-Specialty Hospitals proudly marks its 25th anniversary this year. Established in 1999 by renowned healthcare professionals Dr. Deepak Namjoshi and Dr. Masuuma Namjoshi, CritiCare Asia Hospitals has become a trusted name in medical emergencies. It is committed to providing quality healthcare under the motto “Your Health, Our Concern.”

To commemorate this milestone, CritiCare Asia Hospitals, in partnership with the IIFA Foundation, offers complimentary health check-ups for 500 industry workers, continuing its mission of accessible healthcare for all.

” We founded CritiCare Asia Hospitals with the vision of providing accessible, high-quality healthcare to every individual, regardless of their background. As we celebrate 25 years of service, it’s an honour to give back to the community by offering complimentary health check-ups for 500 industry workers. This initiative, along with @iifa foundation, reflects our ongoing commitment to making healthcare available to not only the star but also the offscreen hero’s, says  Dr. Deepak Namjoshi and Dr. Masuuma Namjoshi

If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

aayush jain acquisition Business cashew processing cote d’ivoire esos 2026 pacific global fzco Pajson Agro pulkit jain Royal Mewa Share Swap

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

All-stock 100% acquisition | ₹354.52 crore | Board also approves ESOS 2026 New Delhi [India], November 6: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012), a vertically integrated cashew processing company with farm-gate sourcing across key producing origins and a growing consumer brand, ‘Royal Mewa’, has announced that its Board of Directors, has approved […]

Read More
Business Fredun Pharmaceuticals EBITDA Growth Fredun Pharmaceuticals H1 FY27 Results Fredun Pharmaceuticals Net Profit Fredun Pharmaceuticals Revenue Growth Indian pharmaceutical industry

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Mumbai (Maharashtra) [India], November 6: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q2 & H1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Key Financial Highlights Standalone key Financial Highlights […]

Read More
Business

Patil Automation Marks a Strong First Half of FY27; Consolidated Revenue Up 37% YoY, Net Profit Up 48%

Mumbai (Maharashtra) [India], November 6: Patil Automation Limited (NSE: PATILAUTOM | INE17GV01016), a leading provider of turnkey welding, assembly and robotics-integrated automation solutions, has released its Unaudited Standalone and Consolidated Financial Results for the half year ended September 30, 2026, reporting broad-based growth across the group. Performance Snapshot – H1 FY27 H1 FY27 Key Financial […]

Read More